The interaction of 3,6- bis(2-pyridyl)-substituted 1,2,4,5-tetrazine with 3,4,5,6-tetrabromo-1,2-dehydrobenzene obtained in situ from the corresponding anthranilic acid was studied for the first time.
The interaction of 3,6- bis(2-pyridyl)-substituted 1,2,4,5-tetrazine with 3,4,5,6-tetrabromo-1,2-dehydrobenzene obtained in situ from the corresponding anthranilic acid was studied for the first time. In this case, instead of the expected product — 5,6,7,8-tetrabromo-1,4-di(2-pyridyl)phthalazine — two alternative transformation products were found, namely 1,2,3,4-tetrabromo-6-methylnaphthalene and 3,6-di(2-pyridyl)pyridazine. The structure of the products was confirmed by physicochemical methods, including X-ray diffraction data. A possible mechanism for this interaction was proposed.
No takes yet. Share an insight, caveat, or question.
S. E. Vatolina (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: